Michael Exton
Director, Chief Executive Officer · 2 filings · Latest: Feb 28, 2026
LEXICON PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
LXRX | Michael Exton | Director, Chief Executive Officer | Feb 28, 2026 | Option Exercise | — | 503,263 | — | 503,263 |